Neutralizing anti-AAV antibody impact on vector transduction following intravitreal administration of AAV in non-human primates

被引：0
|
作者：
Shearman, M. S. [1 ]
Turunen, H. T. [1 ]
Newmark, J. [1 ]
Pennock, S. [1 ]
Timmers, A.
机构：
[1] AGTC, Alachua, FL USA
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P335
引用
收藏
页码：A115 / A116
页数：2
相关论文
共 50 条
  • [21] Neutralizing Antibody Affects Liver-Mediated Factor IX Expression in Non-Human Primates by AAV Vectors
    Mizukami, Hiroaki
    Mimuro, Jun
    Ishiwata, Akira
    Ono, Fumiko
    Yagi, Hiroya
    Urabe, Masashi
    Kume, Akihiro
    Terao, Keiji
    Yasutomi, Yasuhiro
    Sakata, Yoichi
    Ozawa, Keiya
    MOLECULAR THERAPY, 2009, 17 : S314 - S315
  • [22] Characterization of Brain Transduction Capability of a Peptide-Displaying AAV Vector in Mice, Rats and Non-Human Primates
    Bunuales, Maria
    Chillon, Miguel
    Bosch, Assumpcio
    Gonzalez-Aparicio, Manuela
    Garduno, Angeles
    Espelosin, Maria
    Garcia-Gomara, Marta
    Garcia-Osta, Ana
    Cuadrado-Tejedor, Mar
    Lanciego, Jose L.
    Hernandez-Alcoceba, Ruben
    MOLECULAR THERAPY, 2024, 32 (04) : 741 - 741
  • [23] A Novel AAV9 Variant Exhibiting Strong Preference for Neuronal Transduction in Mice and Non-Human Primates Following Systemic Administration
    Huang, Samuel J.
    Adachi, Kei
    Baggett, Helen R.
    Liguore, William A.
    Pincus, Alexandra B.
    McBride, Jodi L.
    Dissen, Gregory A.
    Nakai, Hiroyuki
    MOLECULAR THERAPY, 2020, 28 (04) : 13 - 14
  • [24] NEUTRALIZING ANTIBODY AGAINST VECTOR CAPSID AFFECTS LIVER-MEDIATED FACTOR IX EXPRESSION IN NON-HUMAN PRIMATES USING AAV VECTORS
    Mizukami, Hiroaki
    Mimuro, Jun
    Ishiwata, Akira
    Ono, Fumiko
    Yagi, Hiroya
    Urabe, Masashi
    Kume, Akihiro
    Terao, Keiji
    Yasutomi, Yasuhiro
    Sakata, Yoichi
    Ozawa, Keiya
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1061 - 1062
  • [25] Transcriptomic Disparities Between Male and Female Non-Human Primates Related to AAV Transduction Efficiency
    Kabbej, Nadia
    Ashby, Frederick J.
    Riva, Alberto
    Anyaso-Samuel, Samuel
    Datta, Somnath
    Heldermon, Coy D.
    MOLECULAR THERAPY, 2022, 30 (04) : 439 - 439
  • [26] Dasatinib: A Src Kinase Inhibitor to Prevent Anti-AAV Antibody Response and Enable AAV Re-Administration in Mice
    Xicluna, Rebecca
    Seeger, Emily
    David, Waiz
    Timo, Schwandt
    Haegel, Helene
    MOLECULAR THERAPY, 2023, 31 (04) : 791 - 791
  • [27] AAV8 Vexosome Vectors Enhance Cell Transduction In Vitro and Outperform Conventional AAV8 Vectors in Liver-Transduction In Vivo in the Presence of Anti-AAV Neutralizing Antibodies
    Meliani, Amine
    Fitzpatrick, Zachary
    Charles, Severine
    Mu, Dakai
    Boisgerault, Florence
    Maguire, Casey A.
    Mingozzi, Federico
    MOLECULAR THERAPY, 2015, 23 : S125 - S126
  • [28] Relationship between neutralizing antibody and liver-mediated factor IX expression in non-human primates using AAV vectors
    Mizukami, Hiroaki
    Mimuro, Jun
    Ishiwata, Akira
    Ono, Fumiko
    Yagi, Hiroya
    Urabe, Masashi
    Kume, Akihiro
    Terao, Keiji
    Yasutomi, Yasuhiro
    Sakata, Yoichi
    Ozawa, Keiya
    HUMAN GENE THERAPY, 2009, 20 (11) : 1481 - 1482
  • [29] Characterization of anti-AAV2 neutralizing antibody levels in sheep prior to and following intravitreal AAV2.7m8 injection
    Ross, Maya
    Sade, Kareen
    Obolensky, Alexey
    Averbukh, Edward
    Desrosiers, Melissa
    Rosov, Alexander
    Dvir, Hay
    Gootwine, Elisha
    Banin, Eyal
    Dalkara, Deniz
    Ofri, Ron
    GENE THERAPY, 2024, 31 (11-12) : 580 - 586
  • [30] Successful Repeated Hepatic Gene Delivery in Mice and Non-Human Primates Achieved by Sequential Administration of AAV5 and AAV1 Vector Serotypes
    Majowicz, Anna
    Salas, David
    Zabaleta, Nerea
    Rodriguez-Garcia, Estefania
    Gonzalez Aseguinolaza, Gloria
    Petry, Harald
    Ferreira, Valerie
    MOLECULAR THERAPY, 2016, 24 : S277 - S277
12345